These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


228 related items for PubMed ID: 18464169

  • 21. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
    Tulner LR, Kuper IM, Frankfort SV, van Campen JP, Koks CH, Brandjes DP, Beijnen JH.
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
    [Abstract] [Full Text] [Related]

  • 22. [Polypharmacy in the ambulatory care of aged patients].
    Zanocchi M, Ponzetto M, Spada S, Maero B, Risso R, Aimar T, Fabris F, Friziero M.
    Recenti Prog Med; 1999 Sep; 90(9):455-61. PubMed ID: 10544666
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Polypharmacy in general practice.
    Schaefer K, Maerkedahl H, Birk HO, Henriksen LO.
    Dan Med Bull; 2010 Jul; 57(7):A4165. PubMed ID: 20591340
    [Abstract] [Full Text] [Related]

  • 26. Exposure to potential drug interactions in primary health care.
    Bjerrum L, Andersen M, Petersen G, Kragstrup J.
    Scand J Prim Health Care; 2003 Sep; 21(3):153-8. PubMed ID: 14531506
    [Abstract] [Full Text] [Related]

  • 27. Psychotropic drugs prescription at two regional psychiatric hospitals in northern Nigeria.
    Adeponle AB, Obembe AO, Nnaji F, Adeyemi SO, Suleiman GT.
    West Afr J Med; 2008 Apr; 27(2):106-10. PubMed ID: 19025025
    [Abstract] [Full Text] [Related]

  • 28. Potential determinants of prescribers' drug-drug interaction knowledge.
    Ko Y, Malone DC, D'Agostino JV, Skrepnek GH, Armstrong EP, Brown M, Woosley RL.
    Res Social Adm Pharm; 2008 Dec; 4(4):355-66. PubMed ID: 19064242
    [Abstract] [Full Text] [Related]

  • 29. Prevalence and determinants of pharmacy shopping behaviour.
    Buurma H, Bouvy ML, De Smet PA, Floor-Schreudering A, Leufkens HG, Egberts AC.
    J Clin Pharm Ther; 2008 Feb; 33(1):17-23. PubMed ID: 18211612
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Exposure to potential CYP450 pharmacokinetic drug-drug interactions among osteoarthritis patients: incremental risk of multiple prescriptions.
    Pergolizzi JV, Labhsetwar SA, Puenpatom RA, Joo S, Ben-Joseph R, Summers KH.
    Pain Pract; 2011 Feb; 11(4):325-36. PubMed ID: 21199317
    [Abstract] [Full Text] [Related]

  • 32. [Chronic polypharmacy in one-third of the elderly in family practice].
    Veehof LJ, Stewart R, Haaijer-Ruskamp FM, Meyboom-de Jong B.
    Ned Tijdschr Geneeskd; 1999 Jan 09; 143(2):93-7. PubMed ID: 10086112
    [Abstract] [Full Text] [Related]

  • 33. [Heavy consumers of drugs--seen from the viewpoint of the community pharmacist].
    Mellbye KS, Berg C.
    Tidsskr Nor Laegeforen; 2004 Dec 02; 124(23):3069-71. PubMed ID: 15586191
    [Abstract] [Full Text] [Related]

  • 34. Potential drug interactions and duplicate prescriptions among cancer patients.
    Riechelmann RP, Tannock IF, Wang L, Saad ED, Taback NA, Krzyzanowska MK.
    J Natl Cancer Inst; 2007 Apr 18; 99(8):592-600. PubMed ID: 17440160
    [Abstract] [Full Text] [Related]

  • 35. Potential for drug interactions in hospitalized cancer patients.
    Riechelmann RP, Moreira F, Smaletz O, Saad ED.
    Cancer Chemother Pharmacol; 2005 Sep 18; 56(3):286-90. PubMed ID: 15731916
    [Abstract] [Full Text] [Related]

  • 36. Avoiding polypharmacy and iatrogenesis in the nursing home.
    Daly MP, Lamy PP, Richardson JP.
    Md Med J; 1994 Feb 18; 43(2):139-44. PubMed ID: 8208071
    [Abstract] [Full Text] [Related]

  • 37. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ, Cheng MH, Lee CH, Wung DC, Cheng CL, Kao Yang YH.
    Clin Ther; 2008 Sep 18; 30(9):1726-36. PubMed ID: 18840379
    [Abstract] [Full Text] [Related]

  • 38. Introduction of low dose transdermal buprenorphine -- did it influence use of potentially addictive drugs in chronic non-malignant pain patients?
    Skurtveit S, Furu K, Kaasa S, Borchgrevink PC.
    Eur J Pain; 2009 Oct 18; 13(9):949-53. PubMed ID: 19095476
    [Abstract] [Full Text] [Related]

  • 39. [Pitfalls of polypharmacy, particularly in the elderly].
    Queneau P.
    Bull Mem Acad R Med Belg; 2006 Oct 18; 161(6):408-21; discussion 422-4. PubMed ID: 17288274
    [Abstract] [Full Text] [Related]

  • 40. Is physician adherence to prescription guidelines a general trait of health care practices or dependent on drug type?--a multilevel logistic regression analysis in South Sweden.
    Ohlsson H, Merlo J.
    Pharmacoepidemiol Drug Saf; 2009 Aug 18; 18(8):682-90. PubMed ID: 19437457
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.